NIH ends major grant program for early‑career clinical researchers

The National Institutes of Health announced that it will discontinue a long‑standing grant program that has traditionally supported early‑career clinical investigators, effective at the end of the current fiscal year. The initiative, part of the NIH’s K‑series career development awards, has funded more than 1,200 junior researchers since its inception, providing up to $250,000 in annual support for mentored research projects aimed at translating basic science discoveries into clinical practice. According to the agency’s statement, the decision reflects a strategic reallocation of resources toward larger, collaborative research endeavors and a reassessment of funding mechanisms that better align with evolving public‑health priorities.

The termination of the grant is expected to reduce the pipeline of newly independent clinical researchers, prompting concerns among academic institutions and professional societies that the loss of dedicated career development funding could delay the progression of translational studies. NIH officials indicated that alternative pathways, such as expanded eligibility for existing R‑series awards and new institutional training programs, will be promoted to mitigate the impact. Stakeholders are monitoring the transition as the agency finalizes guidance on the reallocation of remaining funds and the timeline for applicants to complete ongoing projects.